ANUHPHR vs SUDEEPPHRM: Stock Comparison

Anuh Pharma Limited vs Sudeep Pharma Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Sudeep Pharma Ltd is the larger company by market capitalisation. Anuh Pharma Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Sudeep Pharma Ltd shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anuh Pharma Limited and Sudeep Pharma Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANUHPHR is more favourable on 5 of 13 scored metrics and SUDEEPPHRM on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SUDEEPPHRM is the larger company
₹9,323 Cr vs ₹793 Cr
P/E Ratio
ANUHPHR has a lower P/E
19.37x vs 53.82x
P/B Ratio
ANUHPHR has a lower P/B
2.26x vs 10.54x
EPS
SUDEEPPHRM has higher earnings per share
₹15.3 vs ₹4.1
Dividend Yield
ANUHPHR has a higher dividend yield
1.87% vs 0%
Revenue Growth (TTM YoY)
ANUHPHR has faster revenue growth
2% vs 0%
EPS Growth (TTM YoY)
SUDEEPPHRM has faster EPS growth
0% vs -6%
Qtr Sales Growth
SUDEEPPHRM has stronger quarterly sales growth
15.7% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANUHPHRSUDEEPPHRM
SectorHealthcare
IndustryPharmaceuticals

Price

MetricANUHPHRSUDEEPPHRM
Live Price₹79.07₹825.15
Day Change-0.48%1.21%
Volume17,3421.26 L
52-Week High₹101.7₹894.95
52-Week Low₹67₹524.05
Distance from 52W High-22.25%-7.8%

Valuation

MetricANUHPHRSUDEEPPHRM
Market Cap₹793 Cr₹9,323 Cr
P/E Ratio19.37x53.82x
P/B Ratio2.26x10.54x
EPS₹4.1₹15.3
Book Value₹35.28₹78.2
Dividend Yield1.87%0%

Growth

MetricANUHPHRSUDEEPPHRM
Revenue Growth (TTM YoY)2%0%
EPS Growth (TTM YoY)-6%0%
Qtr Sales Growth2.01%15.7%
Qtr Profit Growth-6.26%10.6%

Profitability & Leverage

MetricANUHPHRSUDEEPPHRM
ROE12.1%25.2%
ROCE15.9%28.1%
Net Margin5.32%27.14%
Operating Margin8%34.6%
Debt to Equity0x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricANUHPHRSUDEEPPHRM
Promoter Holding71.78% 0.02 pp76.15%
FII Holding0.05% 0.05 pp1.81% 0.26 pp
DII Holding0%15.65% 2.46 pp
Public Holding28.16% 0.02 pp6.39% 2.21 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anuh Pharma Limited and Sudeep Pharma Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.